[1] |
U.S. Environmental Protection Agency, EPA. Next Generation Risk Assessment: Incorporation of Recent Advances in Molecular, Computational, and Systems Biology [EB/OL]. (2014-09)[2022-02-08]. https://nepis.epa.gov/Exe/ZyPDF.cgi/P100L8P6.PDF?Dockey=P100L8P6.PDF.
|
[2] |
Zhe Su, Feiya Luo, Shuxia Xing, et al. Technical comparison and trend analysis on the topics that ICCR are concerned with[J]. China Surfactant Detergent & Cosmetics, 2021, 51 (11) : 1125-1133.
|
[3] |
International Cooperation on Cosmetics Regulation, ICCR. Integrated Strategies for Safety Assessments of Cosmetic Ingredients - Part Ⅰ [EB/OL]. (2017-06-06)[2022-02-08]. https://www.iccr-cosmetics.org//downloads/topics/iccr-11_jwg_integrated_strategies_integrated_strategies_for_safety_assessments_of_cosmetic_ingredients_-_part_i.pdf.
|
[4] |
International Cooperation on Cosmetics Regulation, ICCR. Integrated Strategies for Safety Assessment of Cosmetic Ingredients: Part 2 [EB/OL]. (2018) [2022-02-08]. https://www.iccr-cosmetics.org//downloads/topics/iccr_integrated_strategies_for_safety_asseassess_of_cosmetic_ingredients_part_2.pdf.
|
[5] |
Camilla A W, Dagmar B, Mark C, et al. A 10-step framework for use of read-across (RAX) in next generation risk assessment (NGRA) for cosmetics safety assessment[J]. Regul. Toxicol. Pharmacol, 2022, 129: 105094.
doi: 10.1016/j.yrtph.2021.105094
|
[6] |
Scientific Committee on Consumer Safety, SCCS. The SCCS Notes of Guidance for the Testing of Cosmetic Ingredients and their Safety Evaluation, 11th revision [R/OL]. (2021-03-31) [2022-02-08]. https://health.ec.europa.eu/publications/sccs-notes-guidance-testing-cosmetic-ingredients-and-their-safety-evaluation-11th-revision_en.
|
[7] |
Guo Jiabin, Shuai Yi. In vitro and predictive toxicology[M]. Beijing: Peking University Medical Press, 2021.
|
[8] |
Organisation for Economic Co-operation and Development, OECD. Case Study on use of an Integrated Approach for Testing and Assessment (IATA) for Systemic Toxicity of Phenoxyethanol when included at 1% in a body lotion. Series on Testing and Assessment, No. 349 [EB/OL]. (2021-10-27)[2022-02-08]. http://t4.oecd.org/officialdocuments/publicdisplaydocumentpdf/?cote=ENV/CBC/MONO(2021)35&docLanguage=En.
|
[9] |
International Cooperation on Cosmetics Regulation, ICCR. Integrated Strategies for Safety Assessment of Cosmetic Ingredients: Workshop report [EB/OL]. (2021) [2022-02-08]. https://www.iccr-cosmetics.org//downloads/topics/2021%20iccr%20integrated%20strategies%20for%20safety%20assessment%20of%20cosmetic%20ingredients%20-%202019% 20worworks%20report.pdf.
|
[10] |
Baltazar M T, Cable S, Carmichael P L, et al. A Next-generation risk assessment case study for coumarin in cosmetic products[J]. Oxford Open, 2020, 176 (1) : 236-252.
|
[11] |
Gautier F, Tou Rn Eix F, Vandecasteele H A, et al. Read-across can increase confidence in the Next Generation Risk Assessment for skin sensitisation: A case study with resorcinol[J]. Regulatory Toxicology and Pharmacology, 2020: 104755.
|
[12] |
Bury D, Alexander-White C, Clewell H J, et al. New framework for a non-animal approach adequately assures the safety of cosmetic ingredients: A case study on caffeine[J]. Regulatory Toxicology and Pharmacology, 2021, 123 (19) : 104931.
doi: 10.1016/j.yrtph.2021.104931
|
[13] |
Vandecasteele H A, Gautier F, Tourneix F, et al. Next generation risk assessment for skin sensitisation: A case study with propyl paraben[J]. Regulatory Toxicology and Pharmacology, 2021, 123: 104936.
doi: 10.1016/j.yrtph.2021.104936
|
[14] |
National Medical Products Administration (NMPA). NMPA Notice about the publication of requirements of information file for new cosmetic ingredient registration or notification (2021 No.31) [EB/OL]. (2021-02-26)[2022-02-08]. https://www.nmpa.gov.cn/zhuanti/hzhpxch2021/hzhp2021fgwj/20210304140454159.html.
|
[15] |
National Medical Products Administration (NMPA). NMPA Notice about the publication of notes of guidance for cosmetic safety evaluation (2021 No.51) [EB/OL]. (2021-04-08)[2022-02-08]. https://www.nmpa.gov.cn/xxgk/ggtg/qtggtg/20210419163037171.html.
|
[16] |
National Medical Products Administration (NMPA). NMPA Notice about the publication of inventory of used cosmetic ingredients (2021 No.62) [EB/OL]. (2021-04-27)[2022-02-08]. https://www.nmpa.gov.cn/zhuanti/hzhpxch2021/hzhp2021fgwj/20210430162707173.html.
|
[17] |
Zhang Fenglan, Shi Yue, Su Zhe, et al. Countermeasures research for safety management of cosmetic ingredients in China[J]. Chinese Pharmaceutical Affairs, 2019, 33 (12) : 6.
|